Warning letter
Immucor, Inc.: warning letter of May 2, 2008
FDA warning letter UCM1048317 · Office of Enforcement
Key facts
| Reference number | UCM1048317 |
|---|---|
| Company | Immucor, Inc. |
| Subject | CGMP Deviations |
| Issue date | May 2, 2008 |
| Posted date | May 2, 2008 |
| Issuing office | Office of Enforcement |
| Product type | Drugs |
| CFR sections cited | 803.50(a) |
| Country | 3 |
| Inspection city | Peachtree Corners |
| Inspection ZIP | 30071-1106 |
| Inspection start date | Jan 8, 2008 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: